Bayer stock gains 15.01% after Roundup trial victory
Published on 10/31/2026 at 10:42 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSRoundup win lifts Bayer focus
- A St. Louis jury backed Monsanto in the first Roundup trial since a favorable US Supreme Court ruling.
- Bayer is still awaiting a decision on its proposed 7.25 billion US dollar settlement covering other claims.
- The legal outcome offers support for Bayer's effort to reduce its long-running litigation burden.
Bayer stock traded at 50.32 euros on Lang & Schwarz at 10:41 CET on Saturday, October 31, 2026, 0.51 percent below the Xetra close of Friday, October 30. The week included a favorable US litigation development as Bayer seeks to reduce the legal burden inherited through Monsanto.
On Thursday, October 29, a St. Louis jury unanimously ruled for Bayer-owned Monsanto in a case brought by three women who said Roundup caused their cancers. Reuters said the trial was the first to reach a verdict after the US Supreme Court limited failure-to-warn claims in June.
Litigation risk remains central
The plaintiffs pursued design-defect, fraud and negligence claims rather than the failure-to-warn theory affected by the Supreme Court ruling. Bayer said the verdict showed the difficulty future plaintiffs could face in proving comparable claims.
The company is separately seeking approval for a proposed 7.25 billion US dollar settlement covering tens of thousands of other Roundup cases. The settlement remains under review by a Missouri state court, so the verdict does not remove the broader litigation issue.
The real-time quote of Bayer stock gives investors a current trading reference, while the Xetra close provides the relevant completed-session comparison.
Bayer stock at a glance
- Company: Bayer Aktiengesellschaft
- ISIN: DE000BAY0017
- Xetra ticker: BAYN.DE
- Lang & Schwarz quote: 50.32 euros, Saturday, October 31, 2026, 10:41 CET
- Change versus Xetra close: 0.51 percent below Friday, October 30
- Xetra close: 50.58 euros, Friday, October 30, 2026
- Weekly Xetra comparison: 15.01 percent above Friday, October 23, 2026
The Euro Stoxx 50 offers the broader European market backdrop for investors assessing Bayer's weekly move.
More news and analyses on Bayer stock will remain relevant as the Missouri court considers the proposed settlement.
